Results 1 to 10 of about 31,650 (136)

Hematolymphoid neoplasms involving the breast: A single institution clinicopathologic study of 59 patients. [PDF]

Ann Hematol
Vickery J, Peerenboom R, Siddiqui F, Joy JA, Prabu SS, Arber DA, Gurbuxani S, Biernacka A, Venkataraman G.   +8 more
europepmc   +1 more source

Outlook of Cell Gene Therapies Development and Approval from Quality and Regulatory Perspective. [PDF]

Ther Innov Regul Sci
Iglesias-Lopez C, Vallano A, Agustí A.
europepmc   +1 more source

The use of venetoclax in the treatment of acute lymphoblastic leukemia-a systematic review. [PDF]

Ther Adv Med Oncol
Kowalczyk A, Zarychta J, Zawitkowska J, Lejman M.   +3 more
europepmc   +1 more source

Clonal Evolution and Lineage Switch from T-Cell Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia in Therapy-Resistant <i>PICALM::MLLT10</i> Leukemia. [PDF]

EJHaem
Kawamura M, Sadato D, Haruta M, Kubota N, Harada Y, Kobayashi T, Doki N, Kasai F, Nishimura Y, Kobayashi H, Maseki N.   +10 more
europepmc   +1 more source

From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy. [PDF]

Front Immunol
Buczek T, Butrym A.
europepmc   +1 more source

Pediatric T-Lymphoblastic Leukemia With Aberrant B-Cell Marker Expression: A Potential Role for Targeted Therapy. [PDF]

EJHaem
Khanlari M, Wang W, Mead PE, Key L, Liu P, Thakral B, Blackburn PR, Klco JM, Ribeiro R, Sarvode S.   +9 more
europepmc   +1 more source

Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL

International Journal of Hematology, 2023
Yasushi Onishi, Yoshihiro Kameoka, Tatsuyuki Kai   +2 more
exaly  

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia

Leukemia and Lymphoma, 2020
Wei Guan, Liping Dou, Li Yu
exaly